Study ID: TV46046-WH-10075
Study Title
- Study to Evaluate Suppression of Ovulation and Pharmacokinetics of Medroxyprogesterone Acetate Following Administration of TV-46046 in Women With Ovulatory Cycle
Teva Identifier
- TV46046-WH-10075
ClinicalTrials.gov Identifier
- NCT02817464
Study Status
- Completed
Trial Condition(s)
- Pregnancy | Contraception
Interventions
- Drug: TV-46046 - 400 mg/mL | Drug: TV-46046 - 200 mg/mL | Drug: TV-46046 - 300 mg/mL (if warranted)
Study Description
- Please refer to ClinicalTrials.gov for a description of the trial
Key Participation Requirements
Gender
- Female
Age Range
- 18 Years to 40 Years
Trial Duration
- October 7, 2016 - December 3, 2018
Phase
- Phase 1
Study Type
Interventional
